Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Biogen Idec
(NQ:
BIIB
)
187.21
+0.15 (+0.08%)
Streaming Delayed Price
Updated: 4:00 PM EDT, May 4, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Biogen Idec
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
59
60
Next >
Health Care Company Biogen Announces Acquisition of Reata Pharmaceuticals
↗
July 28, 2023
Via
Benzinga
Why Is Reata Pharmaceuticals (RETA) Stock Up 53% Today?
↗
July 28, 2023
Reata Pharmaceuticals (RETA) stock is soaring higher on Friday as investors react to an acquisition deal with Biogen (BIIB).
Via
InvestorPlace
Biogen Announces $7.3 Billion Acquisition Of Reata Pharmaceuticals
↗
July 28, 2023
Reata stock surged more than 50% on the news.
Via
Investor's Business Daily
Biogen Bolsters Rare Disease Portfolio, Agrees To Buy Reata Pharmaceuticals With Enterprise Value Of $7.3B
↗
July 28, 2023
Biogen Inc (NASDAQ: BIIB) has agreed to acquire Reata Pharmaceuticals Inc (NASDAQ: RETA) for $172.50 per share in cash, reflecting an enterprise value of
Via
Benzinga
Biogen to Acquire Reata Pharmaceuticals
July 28, 2023
From
Biogen Inc.
Via
GlobeNewswire
I Was Concerned About Biogen Until I Heard These 11 Words From Its CEO
↗
July 27, 2023
Biogen shares have stagnated in recent years, but the company has a plan to change that.
Via
The Motley Fool
Analyst Ratings for Biogen
↗
July 26, 2023
Via
Benzinga
Biogen (BIIB) Q2 2023 Earnings Call Transcript
↗
July 25, 2023
BIIB earnings call for the period ending June 30, 2023.
Via
The Motley Fool
Benzinga's Top Ratings Upgrades, Downgrades For July 27, 2023
↗
July 27, 2023
Via
Benzinga
Neuroinflammation A Key Indicator For Alzheimer’s, But Current Treatments Show Little Success In Reducing Or Even Increase It — Could This Rising Company Have The Answer?
July 27, 2023
--News Direct--
Via
News Direct
Biogen Inc. Tops Q2 Earnings And Revenue Estimates
↗
July 25, 2023
Biogen Inc. came out with quarterly earnings of $4.02 per share.
Via
Talk Markets
Better Big Biotech Buy: Vertex vs. Biogen
↗
July 24, 2023
These companies have a track record of billion-dollar earnings.
Via
The Motley Fool
Biogen Earnings Preview
↗
July 24, 2023
Via
Benzinga
Biogen Unusual Options Activity
↗
July 21, 2023
Via
Benzinga
Why Sage Therapeutics Stock Is Tumbling Today
↗
July 26, 2023
A partner's perceived lack of enthusiasm for an upcoming regulatory decision is spooking investors today.
Via
The Motley Fool
Why Biogen Stock Got Sick Today
↗
July 25, 2023
While the company has won approval for a promising drug, it's cutting costs in the wake of that regulatory green light.
Via
The Motley Fool
Ron DeSantis Escapes Car Accident Unhurt En Route To Campaign Event, TikTok Takes On Twitter, Analysts Expect Nvidia's AI Revenues To Reach $300B In Five Years: Today's Top Stories
↗
July 25, 2023
The Hill Ron DeSantis Escapes Car Accident Unhurt En Route To Campaign Event
Via
Benzinga
WMT Stock Alert: Is Walmart Really Worth $210?
↗
July 25, 2023
Walmart (WMT) stock is in the news Tuesday as investors react to the latest coverage from Piper Sandler analyst Edward Yruma.
Via
InvestorPlace
(BIIB) - Analyzing Biogen's Short Interest
↗
July 20, 2023
Via
Benzinga
Is Biogen Stock a Buy Now?
↗
July 19, 2023
The biotech hasn't been the best investment recently.
Via
The Motley Fool
Should You Buy the Dip With Biogen Stock Right Now?
↗
July 17, 2023
It's expected to grow, but things might not work out precisely as planned.
Via
The Motley Fool
MBLY Stock Alert: Morgan Stanley Restarts Mobileye Coverage
↗
July 25, 2023
Mobileye (MBLY) stock is on the move Tuesday after Morgan Stanley analyst Adam Jonas renewed coverage of the company's shares.
Via
InvestorPlace
Biogen Layoffs 2023: What to Know About the Latest BIIB Job Cuts
↗
July 25, 2023
Biogen (BIIB) layoffs are on the way as the company seeks further profits with its upcoming Alzheimer's disease drug launch.
Via
InvestorPlace
Biogen Q2 Earnings Tops Expectations, Shift Resources To Higher Value Area(s), Layoff 1K Staff
↗
July 25, 2023
Biogen Inc (NASDAQ: BIIB) posted Q2 FY23 sales of $2.46 billion, beating the con
Via
Benzinga
Nasdaq Futures Rise Ahead Of Microsoft, Alphabet Earnings: Analyst Warns Of Volatility From Fed's Message 'Crafting'
↗
July 25, 2023
Via
Benzinga
All Eyes On Biogen's Alzheimer's Drug, A Big Potential Payday, Ahead Of Earnings
↗
July 24, 2023
Analysts expect Biogen to report a a decline in both profits and sales in Q2.
Via
Investor's Business Daily
Goldman Sachs, Charles Schwab And This Healthcare Stock On CNBC's 'Final Trades'
↗
July 21, 2023
On CNBC’s "Halftime Report Final Trades," Joshua Brown of Ritholtz Wealth Management named Biogen Inc.
Via
Benzinga
Eisai Presents Latest Analysis of Lecanemab’s Effect on Biomarker Changes and Subcutaneous Dosing at The Alzheimer’s Association International Conference (AAIC) 2023
July 19, 2023
From
Biogen Inc.
Via
GlobeNewswire
Acumen Soars on Alzheimer's Study...Street Sees It Doubling
July 19, 2023
Will the $11.00 level be a double-top ceiling…or can Acumen Pharmaceuticals build momentum and climb towards its $25.00 IPO price?
Via
MarketBeat
Topics
Initial Public Offering
These 2 Numbers Should Scare Every Biogen Shareholder
↗
July 16, 2023
There are a couple of pieces of evidence that Biogen's long-term strategy isn't working.
Via
The Motley Fool
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
59
60
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
